Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA)
CUSIP: 092667104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Warrants to purchase Class A Common Stock, par value $0.0001 per share
- Shares outstanding
- 85,979,314
- Total 13F shares
- 52,008,284
- Share change
- +2,186,826
- Total reported value
- $250,143,984
- Put/Call ratio
- 13%
- Price per share
- $4.81
- Number of holders
- 125
- Value change
- +$9,910,903
- Number of buys
- 56
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 092667104?
CUSIP 092667104 identifies SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 092667104:
Top shareholders of SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13D/G
13F
|
Company |
7.5%
|
6,404,585
|
$32,407,200 | $0 | 30 Sep 2025 | |
| Third Point LLC |
13D/G
13F
|
Company |
5.8%
|
5,000,000
|
$25,300,000 | $0 | 30 Sep 2025 | |
| Robert S. Wiesenthal |
3/4/5
|
Director |
6.1%
|
5,275,662
|
$23,371,182 | — | 29 Aug 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.1%
from 13D/G
|
4,319,887
mixed-class rows
|
$21,858,385 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
3,380,156
|
$17,103,589 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
3.3%
|
2,821,468
|
$14,276,628 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.1%
|
1,828,621
|
$9,252,822 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
1,825,565
|
$9,237,641 | — | 30 Sep 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.1%
|
1,828,621
|
$9,216,250 | — | 30 Sep 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
2.1%
|
1,793,351
|
$9,074,357 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,607,061
|
$8,133,612 | — | 30 Sep 2025 | |
| CANNELL CAPITAL LLC |
13F
|
Company |
1.9%
|
1,598,489
|
$8,088,354 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,306,416
|
$6,610,465 | — | 30 Sep 2025 | |
| Louis R. Verdetto |
3/4/5
|
CEO Keystone Perfusion Service |
1.5%
|
1,266,025
|
$6,456,727 | — | 02 Dec 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
1.5%
|
1,265,849
|
$6,405,199 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
1,212,979
|
$6,137,675 | — | 30 Sep 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.2%
|
1,041,243
|
$5,268,690 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
791,165
|
$4,003,295 | — | 30 Sep 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.79%
|
682,174
|
$3,451,800 | — | 30 Sep 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
600,221
|
$3,037,118 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.7%
|
598,386
|
$3,027,833 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
493,184
|
$2,495,512 | — | 30 Sep 2025 | |
| Eric L. Affeldt |
3/4/5
|
Director |
0.68%
|
581,214
|
$2,353,916 | — | 01 Aug 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.52%
|
449,608
|
$2,275,016 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.45%
|
389,415
|
$1,970,440 | — | 30 Sep 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.44%
|
374,173
|
$1,893,319 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
300,769
|
$1,521,891 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
259,139
|
$1,311,243 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
255,703
|
$1,293,858 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
253,794
|
$1,284,197 | — | 30 Sep 2025 | |
| Bouvel Investment Partners, LLC |
13F
|
Company |
0.29%
|
246,233
|
$1,245,939 | — | 30 Sep 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.28%
|
244,050
|
$1,234,892 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
233,445
|
$1,181,232 | — | 30 Sep 2025 | |
| Seth J. Bacon |
3/4/5
|
CEO, Trinity Air Medical |
—
class O/S missing
|
340,785
|
$1,001,908 | — | 13 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
188,099
|
$951,782 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
187,890
|
$950,723 | — | 30 Sep 2025 | |
| Edward M. Philip |
3/4/5
|
Director |
0.27%
|
234,165
|
$948,368 | — | 01 Aug 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
183,754
|
$929,795 | — | 30 Sep 2025 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.19%
|
165,550
|
$837,683 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.19%
|
165,234
|
$836,084 | — | 30 Sep 2025 | |
| John Borthwick |
3/4/5
|
Director |
0.24%
|
203,977
|
$826,106 | — | 01 Aug 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.19%
|
160,863
|
$813,967 | — | 30 Sep 2025 | |
| Kenneth B. Lerer |
3/4/5
|
Director |
0.23%
|
196,859
|
$797,278 | — | 01 Aug 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
152,549
|
$771,898 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
152,351
|
$770,896 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.17%
|
150,054
|
$759,273 | — | 30 Sep 2025 | |
| Susan M. Lyne |
3/4/5
|
Director |
0.22%
|
187,185
|
$758,099 | — | 01 Aug 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
145,992
|
$738,720 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.15%
|
129,564
|
$655,585 | — | 30 Sep 2025 | |
| Aspen Grove Capital, LLC |
13F
|
Company |
0.15%
|
125,000
|
$632,500 | — | 30 Sep 2025 |
Institutional Holders of Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) as of Q4 2025
As of 31 Dec 2025,
Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,008,284 shares.
The largest 10 holders included
ARK Investment Management LLC, Third Point LLC, BlackRock, Inc., VANGUARD GROUP INC, Northern Right Capital Management, L.P., AWM Investment Company, Inc., First Eagle Investment Management, LLC, Pillsbury Lake Capital LLC, ROYCE & ASSOCIATES LP, and Amova Asset Management Americas, Inc..
This page lists
125
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
136
Q4 2025 holders
125
Holder diff
-11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.